BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 23 filers reported holding BIOLINERX LTD in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $33,000 | -65.3% | 76,366 | -26.1% | 0.01% | +50.0% |
| Q4 2016 | $95,000 | -18.8% | 103,290 | +1.9% | 0.01% | -27.3% |
| Q3 2016 | $117,000 | +48.1% | 101,390 | +2.8% | 0.01% | 0.0% |
| Q2 2016 | $79,000 | -21.8% | 98,647 | -0.3% | 0.01% | -21.4% |
| Q1 2016 | $101,000 | -12.2% | 98,917 | +11.7% | 0.01% | -6.7% |
| Q4 2015 | $115,000 | +62.0% | 88,517 | +89.5% | 0.02% | +36.4% |
| Q3 2015 | $71,000 | -58.2% | 46,717 | -26.8% | 0.01% | -60.7% |
| Q2 2015 | $170,000 | +5.6% | 63,817 | -16.5% | 0.03% | +33.3% |
| Q1 2015 | $161,000 | – | 76,417 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Senvest Management, LLC | 3,603,300 | $4,684,000 | 0.35% |
| Broadfin Capital, LLC | 3,500,000 | $4,550,000 | 0.28% |
| Opaleye Management Inc. | 250,000 | $325,000 | 0.14% |
| Benchmark Capital Advisors | 47,000 | $61,000 | 0.05% |
| NEXT Financial Group, Inc | 37,500 | $48,000 | 0.02% |
| MENTA CAPITAL LLC | 88,517 | $115,000 | 0.02% |
| Orbimed Advisors | 1,038,600 | $1,350,000 | 0.01% |
| Alyeska Investment Group, L.P. | 444,738 | $578,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 600,000 | $780,000 | 0.00% |
| Airain ltd | 14,674 | $19,000 | 0.00% |